NO20023468L - Vannlöselige prodrugs av azol-forbindelser - Google Patents

Vannlöselige prodrugs av azol-forbindelser

Info

Publication number
NO20023468L
NO20023468L NO20023468A NO20023468A NO20023468L NO 20023468 L NO20023468 L NO 20023468L NO 20023468 A NO20023468 A NO 20023468A NO 20023468 A NO20023468 A NO 20023468A NO 20023468 L NO20023468 L NO 20023468L
Authority
NO
Norway
Prior art keywords
water
azole compounds
soluble prodrugs
soluble
triazole antifungal
Prior art date
Application number
NO20023468A
Other languages
English (en)
Other versions
NO330352B1 (no
NO20023468D0 (no
Inventor
Yasutsugu Ueda
John D Matiskella
Jerzy Golik
Thomas W Hudyma
Chung-Pin Chen
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO20023468D0 publication Critical patent/NO20023468D0/no
Publication of NO20023468L publication Critical patent/NO20023468L/no
Publication of NO330352B1 publication Critical patent/NO330352B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503Five-membered rings
    • C07F9/6506Five-membered rings having the nitrogen atoms in positions 1 and 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6515Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having three nitrogen atoms as the only ring hetero atoms
    • C07F9/6518Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polymerization Catalysts (AREA)
NO20023468A 2000-01-20 2002-07-19 Vannloselige prodrugs av azol-forbindelser, farmasoytiske blandinger omfattende slike, fremgangsmate for fremstilling av slike samt slike forbindelser for behandling av sykdom. NO330352B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17716900P 2000-01-20 2000-01-20
US24996900P 2000-11-20 2000-11-20
PCT/US2001/001284 WO2001052852A1 (en) 2000-01-20 2001-01-16 Water soluble prodrugs of azole compounds

Publications (3)

Publication Number Publication Date
NO20023468D0 NO20023468D0 (no) 2002-07-19
NO20023468L true NO20023468L (no) 2002-07-29
NO330352B1 NO330352B1 (no) 2011-04-04

Family

ID=26873001

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023468A NO330352B1 (no) 2000-01-20 2002-07-19 Vannloselige prodrugs av azol-forbindelser, farmasoytiske blandinger omfattende slike, fremgangsmate for fremstilling av slike samt slike forbindelser for behandling av sykdom.

Country Status (22)

Country Link
US (1) US6362172B2 (no)
EP (1) EP1284737B1 (no)
JP (1) JP3766804B2 (no)
KR (1) KR100748299B1 (no)
CN (1) CN1178665C (no)
AT (1) ATE300946T1 (no)
AU (1) AU782177C (no)
BR (1) BR0107618A (no)
CA (1) CA2397734C (no)
CZ (1) CZ20022822A3 (no)
DE (1) DE60112433T2 (no)
DK (1) DK1284737T5 (no)
ES (1) ES2247131T3 (no)
HU (1) HU229226B1 (no)
IL (2) IL150798A0 (no)
MX (1) MXPA02007120A (no)
NO (1) NO330352B1 (no)
NZ (1) NZ519354A (no)
PL (1) PL206024B1 (no)
PT (1) PT1284737E (no)
RU (1) RU2266909C2 (no)
WO (1) WO2001052852A1 (no)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6448401B1 (en) * 2000-11-20 2002-09-10 Bristol-Myers Squibb Company Process for water soluble azole compounds
HUP0303249A3 (en) 2001-02-22 2007-03-28 Sankyo Co Water-soluble triazole fungicide compounds and pharmaceutical compositions containing them
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
MXPA05001096A (es) 2002-07-29 2005-11-23 Rigel Pharmaceuticals Inc Metodos para tratamiento o prevencion de enfermedades autoinmunes con compuestos de 2,4-diamino-pirimidina.
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE602006010979D1 (de) 2005-01-19 2010-01-21 Rigel Pharmaceuticals Inc Prodrugs aus 2,4-pyrimidindiamin-verbindungen und ihre verwendungen
JO2691B1 (en) * 2005-05-03 2013-03-03 ايساي آر آند دي مانجمنت كو.، ليمتد Monolysine salts for azole compounds
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EP1964843B1 (en) * 2005-12-20 2013-08-28 Eisai R&D Management Co., Ltd. Process for production of water-soluble azole prodrug
WO2007092580A2 (en) * 2006-02-08 2007-08-16 Phibro-Tech Inc. Biocidal azole emulsion concentrates having high active ingredient content
DE602007009489D1 (de) * 2006-02-22 2010-11-11 Eisai R&D Man Co Ltd Stabilisierte pharmazeutische zusammensetzung
CA2810839A1 (en) 2006-05-04 2007-11-15 Boehringer Ingelheim International Gmbh A polymorphic form of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(r)-amino-piperidin-1-yl)-xanthine
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
PE20091730A1 (es) 2008-04-03 2009-12-10 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
JP5757864B2 (ja) 2008-05-20 2015-08-05 ニューロジェシックス, インコーポレイテッド 水溶性アセトアミノフェン類似体
EP2291084A4 (en) 2008-05-20 2012-04-25 Neurogesx Inc CARBONATE PRODRUGS AND METHOD FOR THEIR USE
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
CN102149407A (zh) 2008-09-10 2011-08-10 贝林格尔.英格海姆国际有限公司 治疗糖尿病和相关病症的组合疗法
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
BRPI0923121A2 (pt) 2008-12-23 2015-08-11 Boehringer Ingelheim Int Formas salinas de compostos orgânico
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
CN107115530A (zh) 2009-11-27 2017-09-01 勃林格殷格翰国际有限公司 基因型糖尿病患者利用dpp‑iv抑制剂例如利拉利汀的治疗
KR101927068B1 (ko) 2010-05-05 2018-12-10 베링거 인겔하임 인터내셔날 게엠베하 체중 감소 치료에 후속하는 dpp-4 억제제에 의한 순차적 병용 요법
CN102971005A (zh) 2010-06-24 2013-03-13 贝林格尔.英格海姆国际有限公司 糖尿病治疗
US20130288956A1 (en) 2010-11-05 2013-10-31 Eisai R&D Management Co., Ltd. Combined pharmaceutical composition as antifungal agent
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
RU2734128C2 (ru) * 2010-12-16 2020-10-13 Плэтформ Брайтворкс Ту,Лтд Фармацевтические препараты азолов для парентерального введения и способы их получения и применения для лечения заболеваний, чувствительных к азольным соединениям
EA032840B8 (ru) 2011-06-22 2020-06-18 Вайоми Терапеутикс Лимитед Пролекарства на основе конъюгатов противогрибковых агентов и их применение
EP3517539B1 (en) 2011-07-15 2022-12-14 Boehringer Ingelheim International GmbH Substituted dimeric quinazoline derivative, its preparation and its use in pharmaceutical compositions for the treatment of type i and ii diabetes
US8426450B1 (en) * 2011-11-29 2013-04-23 Helsinn Healthcare Sa Substituted 4-phenyl pyridines having anti-emetic effect
IN2014DN06792A (no) 2012-01-20 2015-05-22 Viamet Pharmaceuticals Inc
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
TWI574705B (zh) 2012-04-20 2017-03-21 衛材R&D企管股份有限公司 Capsules
US20130303462A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
KR101814895B1 (ko) 2013-06-04 2018-01-04 바이옴 바이오사이언스 피브이티. 엘티디. 코팅된 입자 및 이를 포함하는 조성물
MX2016009898A (es) 2014-01-29 2017-01-23 Vyome Biosciences Pvt Ltd Tratamientos para acne resistente.
JP6615109B2 (ja) 2014-02-28 2019-12-04 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Dpp−4阻害薬の医学的使用
CN104926870B (zh) * 2014-03-21 2017-02-08 合肥久诺医药科技有限公司 一种福司氟康唑的精制方法
AU2016298280A1 (en) * 2015-07-28 2018-02-22 Beta Cat Pharmaceuticals, Inc. Anthracene-9, 10-dione dioxime compounds prodrugs and their uses
CA3022202A1 (en) 2016-06-10 2017-12-14 Boehringer Ingelheim International Gmbh Combinations of linagliptin and metformin
CN107501255B (zh) * 2017-09-12 2019-08-23 成都施贝康生物医药科技有限公司 一种艾沙康唑衍生物及其用途
CN108676031A (zh) * 2018-05-29 2018-10-19 重庆威鹏药业有限公司 水溶性三唑类抗真菌膦酸化合物及其制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2111527C (en) 1992-12-24 2000-07-18 Jerzy Golik Phosphonooxymethyl ethers of taxane derivatives
CA2129288C (en) 1993-08-17 2000-05-16 Jerzy Golik Phosphonooxymethyl esters of taxane derivatives
US5714490A (en) * 1993-12-21 1998-02-03 Schering Corporation Tetrahydrofuran antifungals
DK0736030T3 (da) 1993-12-21 2001-10-29 Schering Corp Fungicide tetrahydrofuraner
PL181947B1 (en) 1994-01-24 2001-10-31 Janssen Pharmaceutica Nv Water-soluble azole-type antimycotic agents
NZ270418A (en) 1994-02-07 1997-09-22 Eisai Co Ltd Polycyclic triazole & imidazole derivatives, antifungal compositions
WO1996038443A1 (en) 1995-06-02 1996-12-05 Schering Corporation Tetrahydrofuran antifungals
TW354293B (en) * 1995-06-06 1999-03-11 Bristol Myers Squibb Co Prodrugs of paclitaxel derivatives
GB9602080D0 (en) 1996-02-02 1996-04-03 Pfizer Ltd Pharmaceutical compounds
EP0829478A3 (en) 1996-09-09 1998-03-25 F. Hoffmann-La Roche Ag N-Benzylimidazolium and N-benzyltriazolium derivatives, their preparation and their use as antifungal and antimycotic agents
DE69912250T2 (de) 1998-01-29 2004-07-29 Bristol-Myers Squibb Co., Wallingford Phosphorylierte derivate des diaryl 1,3,4 oxadiazolon
US5883097A (en) 1998-04-16 1999-03-16 Schering Corporation Soluble azole antifungal salt
US6204257B1 (en) * 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
WO2000030655A1 (en) * 1998-11-20 2000-06-02 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
US6448401B1 (en) * 2000-11-20 2002-09-10 Bristol-Myers Squibb Company Process for water soluble azole compounds

Also Published As

Publication number Publication date
EP1284737B1 (en) 2005-08-03
HUP0204405A3 (en) 2005-02-28
HU229226B1 (en) 2013-09-30
DE60112433D1 (de) 2005-09-08
KR20020070492A (ko) 2002-09-09
IL150798A (en) 2006-08-01
DK1284737T5 (da) 2007-09-24
CA2397734C (en) 2010-08-17
US20010041691A1 (en) 2001-11-15
ES2247131T3 (es) 2006-03-01
AU782177B2 (en) 2005-07-07
DK1284737T3 (da) 2005-11-28
NO330352B1 (no) 2011-04-04
BR0107618A (pt) 2002-11-12
KR100748299B1 (ko) 2007-08-09
JP3766804B2 (ja) 2006-04-19
HUP0204405A2 (en) 2003-05-28
PL206024B1 (pl) 2010-06-30
NZ519354A (en) 2004-05-28
AU782177C (en) 2007-10-18
PL356164A1 (en) 2004-06-14
CZ20022822A3 (cs) 2003-02-12
AU2948501A (en) 2001-07-31
JP2003520235A (ja) 2003-07-02
MXPA02007120A (es) 2003-01-28
CN1178665C (zh) 2004-12-08
US6362172B2 (en) 2002-03-26
NO20023468D0 (no) 2002-07-19
WO2001052852A1 (en) 2001-07-26
RU2266909C2 (ru) 2005-12-27
EP1284737A4 (en) 2003-03-19
CA2397734A1 (en) 2001-07-26
EP1284737A1 (en) 2003-02-26
ATE300946T1 (de) 2005-08-15
IL150798A0 (en) 2003-02-12
DE60112433T2 (de) 2006-05-18
PT1284737E (pt) 2005-11-30
CN1395485A (zh) 2003-02-05

Similar Documents

Publication Publication Date Title
NO20023468D0 (no) Vannlöselige prodrugs av azol-forbindelser
WO2001051456A3 (en) Antibacterial agents
AU781393C (en) Slot machine having multiple progressive jackpots
AU2002219718A1 (en) Process for oxidising primary alcohols
AU2001243370A1 (en) Residential septic tank
AU2001283989A1 (en) Surface-active photoinitiators
SE0004245D0 (sv) Novel compounds and their use
MXPA03005143A (es) Fotoiniciadores tensoactivos.
NO20032241D0 (no) Forbedret prosess for vannlöselige azolforbindelser
MXPA03000687A (es) Composiciones de policarbonato ignifugas.
AU2002213459A1 (en) Phosphorus-silicate fibers suitable for extended band amplification
AUPQ629000A0 (en) Inhibition of fungi
AU2002211050A1 (en) Streptomyces kasugaensis inhibiting the fungal pathogens of plant
AU6900001A (en) Improving the performance of a cdma system
ZA200303082B (en) Calcilytic compounds.
AU2001226604A1 (en) Fluted static stack agitator
UY26541A1 (es) Profármacos de compuestos de azol solubles en agua.
AU2001279272A1 (en) Blot organizer
AU2001243274A1 (en) Dsl repeater
AU2002217792A1 (en) Writable document protector assembly
AU2000236832A1 (en) Double axled rotationturbine
IT1317718B1 (it) Benzilisotiouree ad attivita' fungicida.
AU2001254542A1 (en) Inhibition of yellowing in papers
AU2001282779A1 (en) Ventilated work chamber arrangement
AU2002210437A1 (en) Organizer

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees